CVE-2026-47664: Pathling is a set of tools that make it easier to use FHIR and clinical terminology within health data analyti
CVE-2026-47664 is a high-severity flaw (CVSS 8.6) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Pathling is a set of tools that make it easier to use FHIR and clinical terminology within health data analytics. Prior to version 2.0.0 of Pathling Server, the `$import-pnp` operation in Pathling Server accepts a caller-supplied `exportUrl` and uses it as the remote FHIR Bulk Export endpoint without constraining it to a trusted source. When PNP credentials are configured, Pathling builds a credentialed bulk-export client targeting the caller-cho
Why this priority
- High severity
- CISA SSVC: public proof of concept
A fixed release or distro patch exists.
Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Exact fixes by distribution
Public exploits and detection
Public code exists for this CVE. Treat unpatched systems as at risk, and only run PoCs in a lab.
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-47664?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-47664 being exploited?
CVE-2026-47664 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-47664 affect?
CVE-2026-47664 affects affected software. Severity is high (CVSS 8.6). Pathling is a set of tools that make it easier to use FHIR and clinical terminology within health data analytics. Prior to version 2.0.0 of Pathling Server, the `$import-pnp` operation in Pathling Server accepts a caller-supplied `exportUrl
How urgent is CVE-2026-47664?
Priority 36/100. High severity; CISA SSVC: public proof of concept